Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Twitter Inc (TWTR) Reports Second Quarter Earnings Beat, But Slumps On Weak User Growth: Chance To Buy?

Page 1 of 2

Twitter Inc (NYSE:TWTRreported its second quarter financial results on Tuesday, and though the social media giant managed to beat the Street’s expectations for the quarter and shares initially gained as much as 6% in the after-hours trading, they quickly sank once investors dug further into the results and are now trading down by nearly 13% in morning trading. Twitter Inc (NYSE:TWTR) reported adjusted earnings of $0.07 per share, which surpassed the consensus expectation of $0.04 and was also $0.05 more than the earnings it posted during the same period of 2014. On the revenue side, the company reported total revenue of $502 million for the quarter, $20.7 million more than the consensus expectation and $190 million more than a year ago. Twitter’s ad business showed tremendous growth in the quarter, with ad revenues going up by 61% during the period, the majority of which was attributable to its mobile platform. Revenues from smartphones contributed 88% of Twitter’s total revenue for the quarter.


There was graver concern though regarding the social media platform’s user growth, which decelerated during the quarter. Twitter reported user growth of 2.61% to 316 million. Interim CEO of Twitter, Jack Dorsey also shared his disappointment on the drop after a strong earnings report. “Our Q2 results show good progress in monetization, but we are not satisfied with our growth in audience,” Dorsey was quoted as saying in a company statement. Twitter Inc (NYSE:TWTR)’s stock started the year at around $35 per share, before going up and above $50 per share by April, being one of the top performing stocks of the first quarter, but later that month plunged on its first quarter earnings and has performed an encore with its second quarter earnings. Shares are now down by more than 11% year-to-date.

The poor user growth will prove disappointing to many hedge funds, who were putting their faith in the stock in greater numbers at the start of the year. At the end of the first quarter, a total of 64 of the hedge funds tracked by Insider Monkey were bullish on Twitter Inc (NYSE:TWTR), with a total investment of $1.75 billion. At the end of 2014, there were only 42 hedge funds with $1.01 billion invested in the stock. Compared to a 40% stock value appreciation during the January – March period, a 75% increase in investment shows that the smart money was adding shares to their portfolios. But since the end of the first quarter, the stock has lost around 30% of its value.

John Thaler‘s JAT Capital Management had the biggest position in Twitter Inc (NYSE:TWTR) with around 7.3 million shares worth close to $363.7 million at the end of March. OZ Management, led by Daniel S. Och, held around 4.5 million shares valued at $225.5 million, while Daniel Benton’s Andor Capital Management, Jim Simons‘ Renaissance Technologies and David E. Shaw’s D E Shaw also held large positions in the stock. OZ Management also initiated the largest new position in Twitter Inc (NYSE:TWTR) during the quarter, while Renaissance Technologies opened a new position of 2.6 million shares. Peter Muller’s PDT Partners, Doug Gordon, Jon Hilsabeck, and Don Jabro’s Shellback Capital, and Nick Niell’s Arrowgrass Capital Partners were among the other funds showing faith in Twitter.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!